Electra Therapeutics Raises $183 Million in Series C Round
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 – Electra Therapeutics, a clinical-stage biotechnology company pioneering next-generation therapies for diseases in immunology and cancer, today announced the successful close of an […]